Muutke küpsiste eelistusi

E-raamat: Genomic Epidemiology Data Infrastructure Needs for SARS-CoV-2: Modernizing Pandemic Response Strategies

  • Formaat: 110 pages
  • Ilmumisaeg: 29-Sep-2020
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309680943
  • Formaat - EPUB+DRM
  • Hind: 71,49 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: 110 pages
  • Ilmumisaeg: 29-Sep-2020
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309680943

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

In December 2019, new cases of severe pneumonia were first detected in Wuhan, China, and the cause was determined to be a novel beta coronavirus related to the severe acute respiratory syndrome (SARS) coronavirus that emerged from a bat reservoir in 2002. Within six months, this new virusSARS coronavirus 2 (SARS-CoV-2)has spread worldwide, infecting at least 10 million people with an estimated 500,000 deaths. COVID-19, the disease caused by SARS-CoV-2, was declared a public health emergency of international concern on January 30, 2020 by the World Health Organization (WHO) and a pandemic on March 11, 2020. To date, there is no approved effective treatment or vaccine for COVID-19, and it continues to spread in many countries.





Genomic Epidemiology Data Infrastructure Needs for SARS-CoV-2: Modernizing Pandemic Response Strategies lays out a framework to define and describe the data needs for a system to track and correlate viral genome sequences with clinical and epidemiological data. Such a system would help ensure the integration of data on viral evolution with detection, diagnostic, and countermeasure efforts. This report also explores data collection mechanisms to ensure a representative global sample set of all relevant extant sequences and considers challenges and opportunities for coordination across existing domestic, global, and regional data sources.

Table of Contents



Front Matter Summary 1 Introduction 2 Application of Genomic Epidemiology in Previous Infectious Disease Outbreaks 3 Current Genomic Epidemiology Efforts Related to SARS-CoV-2 4 Framework to Track and Correlate Viral Genome Sequences with Clinical and Epidemiological Data 5 Governance and Regulatory Considerations Appendix A: Committee Biosketches Appendix B: Public Committee Meeting Agendas
Acronyms And Abbreviations xiii
Summary 1(8)
1 Introduction
9(10)
Coronavirus Evolution and SARS-CoV-2
10(1)
The Power of Genomics in Understanding SARS-CoV-2
11(3)
Study Charge
14(2)
About This Report
16(1)
References
16(3)
2 Application Of Genomic Epidemiology In Previous Infectious Disease Outbreaks
19(14)
Previous Efforts to Integrate Analyses of Genomic, Clinical, and Epidemiological Data
19(6)
Best Practices and Keys to Future Success
25(2)
References
27(6)
3 Current Genomic Epidemiology Efforts Related To Sars-Cov-2
33(14)
Current SARS-CoV-2 Data Sources
33(8)
Current Efforts to Integrate SARS-CoV-2 Genome Sequence Data with Clinical and Epidemiological Data
41(2)
Concluding Remarks
43(1)
References
44(3)
4 Framework To Track And Correlate Viral Genome Sequences With Clinical And Epidemiological Data
47(22)
Considerations for Transmission, Evolution, and Clinical Disease
47(9)
Opportunities to Support Data Integration
56(1)
Infrastructure Needs
57(5)
Partnerships, Coordination, and Capacity Considerations
62(1)
Concluding Remarks
63(1)
References
64(5)
5 Governance And Regulatory Considerations
69(16)
Federalism Barriers and Opportunities
70(1)
International Sharing Barriers
70(2)
Perceived Versus Actual Domestic Legal Barriers
72(1)
The Health Insurance Portability and Accountability Act (HIPAA)
72(4)
Common Rule
76(4)
Governance
80(1)
Concluding Remarks
81(2)
References
83(2)
APPENDIXES
A COMMITTEE BIOSKETCHES
85(8)
B PUBLIC COMMITTEE MEETING AGENDAS
93